Wayne, PA – Genex Services recently announced that it has been awarded full Independent Medical Examinations (IME) v1.0 accreditation by URAC, the leading accreditation organization for health care providers. The approval places Genex as one of the first IME programs to be awarded this new URAC certification.
The URAC accreditation seal symbolizes that an organization is going beyond regulatory compliance in its IME operations to represent its commitment to excellence in its services to purchasers, patients and providers. Meeting the objectives of URAC accreditation assures clients they will receive accurate, trustworthy decisions backed by comprehensive, evidence-based review. The URAC IME accreditation provides a roadmap to ensure regulatory compliance requirements are continuously being met, giving patients and payers confidence that Genex examiners are highly qualified and knowledgeable in their field, and most importantly, committed to fair and ethical care practices.
Genex’s nationwide IME program is designed to eliminate provider risk, enhance physician exam and report quality and reduce administrative burden. The program uniquely integrates hard data, clinical expertise, and rigorous quality analysis standards to deliver an easy-to-use, trustworthy IME process for customers and claimants to receive an accurate, defensible decision, every time.
URAC had previously recognized IME organizations solely through its Independent Review Organization program. However, since many URAC-accredited companies provide both independent review and independent medical examination services, officials recently developed a program for organizations whose business models support the IME function exclusively. This resulted in the IME v1.0 accreditation.
“We are extremely proud to have our program be among the first in our industry to receive the URAC IME v1.0 accreditation,” said Rich Leonardo, Genex Senior Vice President, IME and Specialty Services. “Over the years, we have earned the trust of insurance industries we serve, including workers’ comp, auto and disability, through the quality of our IME program and the medical expertise of our examiners. Being one of the first to earn this new accreditation validates the excellent standards we have set for Genex IME, especially when it comes to quality analysis, which is a hallmark of our services.”
To earn the IME accreditation, Genex underwent a rigorous external evaluation of its program by URAC, which includes extensive documentation, validation, and committee review. Securing URAC IME accreditation provides value to claimants as well as clients by offering:
- Third-party validation that a high-quality program offers a truly independent, fair recommendation that does not tip the scale toward the claimant nor payer
- Thorough policies, procedures and documentation that reduce the administrative burden of claim disputes
- Risk management oversight and review protocols that reduce client liabilities, enhance data security and ensure regulatory compliance
- Ongoing operational efficiency and program improvement.
Genex holds the IME v1.0 accreditation for three years — April 1, 2021 to April 1, 2024 — after which, the program must undergo a renewal process to maintain its standing.
Source: Genex Services
Genex Services is a WorkCompWire ad partner.
This is not a paid placement.